Introduction
Propranolol hydrochlorid (PRO), 1-[isopropylamino-3-(1-naphthyloxy)-2-propanol], has recently been introduced as a drug as a β-adrenoceptor antagonist; it finds extensive application in the therapy of hypertension, angina pectoris, cardiac arrhythmia, and hypertrophic subaortic stenosis in clinical practice. 1, 2 Owing to its sedative effect due to reducing cardiac frequency and contraction force, it has been used as a doping agent in sports. The International Olympic Committee has forbidden it in some events such as shooting and weightlifting. PRO is not an endogenous substance, and the results of examination should be considered as positive once it is detected in a urine sample. 1, 3, 4 Therefore, the development of a simple, quick and sensitive method to examine PRO is necessary.
Current methods for the detection of PRO include spectrophotometry, FI-CL, AAS, HPLC and LC-MS. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] However, spectrophotometry was not sensitive for determination of PRO, the use of spectrofluorometry for determining drugs in biological fluids was made difficult by the presence of natural fluorescent interferences, FI-CL had low sensitivity and poor reproducibility, and AAS and HPLC demanded complex extraction procedures and pretreatments such as preconcentration in an organic solvent or proteins precipitation and are not environmentally friendly. In addition, mass spectrometry provides the high recorded mass resolution, high sensitivity and good reproducibility, but it requires access to an expensive mass spectrometer. Because of the complex function of mass spectrometry, many parameters (excitation, trapping, detection conditions) comprise the experiment sequence that defines the quality of the mass spectrum and the instrument needs careful maintenance.
In recent years, capillary electrophoresis (CE) has gradually become an important and powerful analytical tool in pharmaceutical analysis because of the small sample size, high sensitivity, rapidity, short analysis time, and low operational cost. 14, 15 On the other hand, electrochemiluminescence (ECL) was applied to a variety of fields such as biosensors, immunoassays, and flow injection analysis, due to its simplicity, inherent sensitivity, low background noise, good selectivity, and wide linear range. 16, 17 ECL using a tris(2,2′-bipyridyl)-ruthenium(II) (Ru(bpy)3
2+
) system has been extensively studied and the combination of CE and ECL using Ru(bpy)3 2+ has been studied since the mid-to-late 1990s for the determination of various analytes. 16, [18] [19] [20] [21] [22] [23] [24] In this research, it was found that the weak ECL signal from the electrochemical oxidization of Ru(bpy)3 2+ was greatly enhanced by PRO. Based on this observation, CE coupled with ECL detection was used for the determination of the pharmacokinetics of PRO in human urine. The method was simple, quick, and sensitive.
Experimental

Reagents and chemicals
Propranolol hydrochloride was obtained from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Tris(2,2′-bipyridyl)ruthenium(II) chloride hexahydrate was purchased from Alfa Aesar (A Johnson Matthey Company, Ward Hill, MA) and used without further purification. The required sample solutions and phosphate buffer solution (PBS) were passed through 0.45 μm filters A novel method for the determination of propranolol hydrochlorid (PRO) in human urine was developed using capillary electrophoresis coupled with electrochemiluminescence detection (CE-ECL). The parameters that affected the separation and detection were optimized. Under the optimal conditions, the linear range for PRO was from 0.003 to 2 μg/mL (r 2 = 0.9993), and the detection limit was 1.3 ng/mL (S/N = 3). The method was successfully applied to the study of the pharmacokinetics of PRO in human urine. The relative standard deviations of ECL intensity and migration time were 2.6 and 2.1%, respectively (1.0 μg/mL PRO, n = 6). The recovery was between 96.71 and 97.30%. The peak excretion rate in urine was observed during the 0.5 -1 h after oral administration of a 10-mg PRO tablet and the urinary excretion ratio of PRO was 13.6% within 12 h. The method was simple, rapid, economical and sensitive, and may improve the detection of PRO as a doping agent in sports. (Shanghai Xinya Purification Material Factory, Shanghai, China) before being injected into the CE system. All reagents were of analytical grade. All solutions in the experiments were prepared with double-distilled water (DDW) and stored in refrigerator at 4 C.
Apparatus and procedure
The MPI-B CE-ECL (Xi'an Remex Electronic Science-Tech Co., Ltd., Xi'an, China) was used. The CE-ECL detection cell has been described previously. 25 The end-column ECL cell was composed of a three-electrode system, with 300 μm diameter Pt disk as the working electrode, a Pt wire as the counter electrode, and a Ag/AgCl electrode as the reference electrode. All electrophoretic experiments were performed with a 50-cm uncoated silica capillary (75 μm i.d., 375 μm o.d.) (Yongnian Optical Fiber Co., Hebei, China). The capillary was filled with 0.1 mol/L NaOH for 24 h before use and then rinsed with filtered DDW for 30 min by means of a syringe and then became ready for use. 26 Before each run, the capillary was flushed with filtered DDW and the corresponding running buffer for about 5 and 10 min, successively.
After each CE run, the electrode was treated with a cyclic voltammetry scan in a potential range of 0.2 to 1.35 V at 100 mV/s until the cyclic voltammogram is stable. Approximately 300 μL of Ru(bpy)3 2+ (5 mmol/L) in PBS (50 mmol/L, pH 8.0) was placed in the ECL detection cell for ECL measurement. The Ru(bpy)3
2+
-PBS was replaced every 3 h during the experiments to avoid errors in ECL measurement due to possible changes in the Ru(bpy)3 2+ concentration. The distance between the working electrode and the exit end of capillary was fixed at 200 μm. The concentration of running PBS was 10 mmol/L with pH 7.5, and the material was replaced between runs. The applied potential was 1.3 V. The separation voltage was 12 kV.
Injection parameters were set to 12 s × 14 kV. The CE-ECL system worked at room temperature (25 C).
Sample preparation
The urine sample was taken from a healthy female volunteer (25 years old, 44 kg). The volunteer was dosed with 10 mg PRO tablet and had abstained from any medications during the week preceding the study. If the urine sample was directly injected into the capillary, proteins and other biomolecules presented in the urine matrix could be adsorbed to the wall of the capillary and could affect the separation of the drug. 27, 28 In order to obtain a clear electropherogram, high reproducibility and detection sensitivity, getting rid of interferential compounds was necessary. 15, 29, 30 In this paper, the urine samples were mixed with 50 μL 0.1 mol/L NaOH and 2 mL ethyl acetate, shaken for 5 min and centrifuged for 10 min at 12000 r/min. 31 The upper layer was transfered to a clean tube and dried under a stream of dry nitrogen at 80 C. Subsequently, the dry residue was dissolved in 200 μL of DDW, and the solution was filtered before analysis.
Results and Discussion
Cyclic voltammetry analysis
The ECL intensity was dependent on the rate of the light-emitting chemical reaction. Cyclic voltammetry (CV) was used to characterize the ECL behavior of PRO. As shown in Fig. 1 , ECL intensity began to increase rapidly at 1.10 V (curve a), and about 100 counts were displayed when the potential was close to 1.30 V. As a comparison, when PRO was added, the ECL intensity was increased significantly to about 500 counts (curve b). We can conclude that PRO can react with the ruthenium species in the ECL process, and it can enhance the emitted light intensity. Consequently, a new method for the determination of PRO was established using CE-ECL.
Detection potential
The optimum potential applied to the working electrode should be selected to achieve the best detection results. We thus further investigated the effect of applied potential on ECL intensity and signal to noise ratio (S/N) (Fig. 2) . The ECL intensity and S/N were studied on a series of voltages from 1.15 to 1.45 V, and the results were correlated with the cyclic voltammetry experiments described above. As seen in Fig. 2 , ECL intensity and S/N all attained maximum values when the detection voltage was 1.30 V. With the the increasing detection potential, the ECL intensity and S/N decreased. Thus, the detection potential was fixed at 1.30 V in subsequent experiments. 
Buffer pH and concentration
The phosphate buffer pH has a very important function in the ECL cell and in the running buffer. In order to obtain the optimal sensitivity and suitable EOF, we studied a series of pH in ECL cell and running buffer pH. For the purpose of achieving a relatively high ECL intensity with moderate reagent consumption, 5 mmol/L Ru(bpy)3 2+ was used in this study. Previous work indicated that, when the concentration of Ru(bpy)3 2+ was 5 mmol/L, Ru(bpy)3 2+ had a good ECL efficiency. 22, 28 As shown in Fig. 3 , maximum ECL intensities are displayed at pH 8.0 and 7.5 in ECL cell and running buffer, respectively. Therefore, the optimal buffer pH values of 8.0 and 7.5 were selected for the experimental conditions.
Besides pH of the running buffer, its concentration also plays an important role. The ECL intensity was carefully investigated when the buffer concentration changed from 6 to 20 mmol/L. The highest ECL intensity was obtained at a running buffer concentration of 10 mmol/L, as we can see from Fig. 4 . The buffer in the ECL cell and the running buffer in CE do not have the same role. When the pH 7.5 running buffer in CE and the pH 8.0 buffer in the detection cell were mixed, the pH in the detection cell may become the suitable pH. When low concentration (<10 mM) buffer in CE was mixed with the buffer in the detection cell, a spot of the running buffer flowed into the cell, resulting in the pH of the mixed buffer in the detection cell being less than that of the optimized pH value. Therefore, ECL intensity was lower than that of the optimized pH value. When high concentration (>10 mM) buffer in CE was mixed with the buffer in the detection cell, this led to the pH of the mixed buffer in the detection cell being more than that of the optimized pH value. So, the intensity decreased. In the end, 10 mmol/L PBS exhibited optimal ECL detection and was used as the CE running buffer in the following work.
Running voltage
The influence of running voltage on ECL intensity was examined from 6 to 20 kV. ECL intensity increased with running voltage up to 12 kV, then it dropped as the voltage was further increased. At the same time, the noise of the background increased with the voltage, possibly due to the effect of high Joule heat. 32 In view of these reasons, 12 kV was selected as the running voltage.
Injection voltage and injection time
When the injection voltage was higher than 14 kV, the curve of ECL intensity and injection voltage deviated from linearity. Previous references reported that the ECL intensity is dependent on the concentration of the analyte in the diffusion layer on the working electrode, where the chemiluminescence reaction takes place. 33, 34 More analyte may enter into the diffusion layer to get a higher ECL signal with the increasing injection voltage. However, the analyte cannot reach the electrode surface immediately and diffuses into the solution in the cell, which may cuase the peak of ECL intensity to be delayed and broadened. Considering the high ECL intensity and the improved column efficiency, we chose 14 kV for the injection voltage.
The effects of injection time on ECL intensity were studied (Fig. 5) . The longer injection time led to stronger ECL signal and lower separation efficiency due to the introduction of more analyte in the detection cell. 28 Therefore, in order to avoid the unfavorable conditions, we chose the electrokinetic injection of 12 s at 14 kV as a compromise. 
Linearity, detection limit and reproducibility
Under optimal detection conditions, the calibration curve was linear from 0.003 to 2 μg/mL with a regression curve of I = 1661x + 38.95 (r 2 = 0.9993, x unit for μg/mL). The detection limit was 1.3 ng/mL (S/N = 3). The detection limit was better than those of previous reports (from 5.1 to 4.97 mg/L). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The relative standard deviations (RSD) of the ECL intensity and the migration time for six consecutive injections of 1.0 μg/mL PRO were 2.6 and 2.1%, respectively.
Application to human urine
The available information suggests that excretion of the parent drug is via urine and bile. 35 The CE-ECL method developed in this paper is proposed for assaying PRO in human urine samples. The extraction procedure was shown in the Experimental section and a typical electropherogram is shown in Fig. 6 . We identified the peaks of PRO by comparing the migration times of urine sample and spiked urine sample with those of standard solutions. 32 The urine samples were determined through parallel experiments (Fig. 6) . Components of the urine were successfully separated (Fig. 6B) . Figure 6C showed an electropherogram of the human urine sample spiked with 0.23 μg/mL PRO. Comparing Figs. 6B and 6C, one finds the migration time of peak d to be 207 s. The intensity of peak d in curve C was enhanced obviously, whereas the ECL intensity and the migration time of the unknown peaks were almost unchanged. Therefore, the peak at 207 s was the PRO peak. The peak a might be generated by amino acids in human urine. The peaks b and c in the urine sample were from the metabolites of PRO in vivo.
Under optimal detection conditions, the content of PRO determined by CE-ECL in human urine was 58.43 ng/mL 2 h after drug administration. The recoveries of PRO in urine samples were between 96.71 and 97.30%. The RSD of ECL peak intensity was less than 3%.
Pharmacokinetics of PRO
The collected urine samples were used as blank samples half an hour before medication. The urine samples were collected at 0.25, 0.5, 1, 1.5, 2, 4, 5, 7, 9 and 12 h after drug administration, and the volume was noted. The volunteer was asked to drink 150 mL of water after every collection.
We accounted for the concentrations of PRO in the urine samples according to the linear regression equation. The excretion amounts of PRO were obtained by multiplying the PRO concentration with the volume of urine. 31 The relationship between the excretion rate and the center of time interval was shown in Fig. 7 . The corresponding time divided by the amount of excreted parent drug at each distance of dwell time is defined as the excretion rate of PRO. The peak excretion rate in urine was observed between 0.5 and 1 h after oral administration of 10 mg PRO tablet. The results obtained indicate that the urinary excretion ratio of PRO was 13.6% within 12 h. According to previous report (14.7 ± 2.46%), the value of the excretion ratio was reasonable. 36 
Conclusions
This work presents a simple, rapid, economical and sensitive CE-ECL method for the determination of PRO. It was successfully applied to pharmacokinetics and bioavailability studies on PRO in human urine after the administration of PRO tablets. In addition, the proposed method may improve the detection of PRO as a doping agent in sports. Fig. 6 Electropherogram of blank urine sample (A), the urine sample 2 h after drug administration (B), and urine sample spiked with 0.23 μg/mL PRO (C). Detection conditions were shown in Experimental. Fig. 7 Relationship of excretion rate of PRO in urine and time. Detection conditions were shown in Experimental.
